Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Clozapine for medication-related pathological gambling in Parkinson disease.

Identifieur interne : 001698 ( PubMed/Corpus ); précédent : 001697; suivant : 001699

Clozapine for medication-related pathological gambling in Parkinson disease.

Auteurs : Alessandro Rotondo ; Domenico Bosco ; Massimiliano Plastino ; Arturo Consoli ; Francesca Bosco

Source :

RBID : pubmed:20669252

English descriptors


DOI: 10.1002/mds.23177
PubMed: 20669252

Links to Exploration step

pubmed:20669252

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Clozapine for medication-related pathological gambling in Parkinson disease.</title>
<author>
<name sortKey="Rotondo, Alessandro" sort="Rotondo, Alessandro" uniqKey="Rotondo A" first="Alessandro" last="Rotondo">Alessandro Rotondo</name>
</author>
<author>
<name sortKey="Bosco, Domenico" sort="Bosco, Domenico" uniqKey="Bosco D" first="Domenico" last="Bosco">Domenico Bosco</name>
</author>
<author>
<name sortKey="Plastino, Massimiliano" sort="Plastino, Massimiliano" uniqKey="Plastino M" first="Massimiliano" last="Plastino">Massimiliano Plastino</name>
</author>
<author>
<name sortKey="Consoli, Arturo" sort="Consoli, Arturo" uniqKey="Consoli A" first="Arturo" last="Consoli">Arturo Consoli</name>
</author>
<author>
<name sortKey="Bosco, Francesca" sort="Bosco, Francesca" uniqKey="Bosco F" first="Francesca" last="Bosco">Francesca Bosco</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="doi">10.1002/mds.23177</idno>
<idno type="RBID">pubmed:20669252</idno>
<idno type="pmid">20669252</idno>
<idno type="wicri:Area/PubMed/Corpus">001698</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Clozapine for medication-related pathological gambling in Parkinson disease.</title>
<author>
<name sortKey="Rotondo, Alessandro" sort="Rotondo, Alessandro" uniqKey="Rotondo A" first="Alessandro" last="Rotondo">Alessandro Rotondo</name>
</author>
<author>
<name sortKey="Bosco, Domenico" sort="Bosco, Domenico" uniqKey="Bosco D" first="Domenico" last="Bosco">Domenico Bosco</name>
</author>
<author>
<name sortKey="Plastino, Massimiliano" sort="Plastino, Massimiliano" uniqKey="Plastino M" first="Massimiliano" last="Plastino">Massimiliano Plastino</name>
</author>
<author>
<name sortKey="Consoli, Arturo" sort="Consoli, Arturo" uniqKey="Consoli A" first="Arturo" last="Consoli">Arturo Consoli</name>
</author>
<author>
<name sortKey="Bosco, Francesca" sort="Bosco, Francesca" uniqKey="Bosco F" first="Francesca" last="Bosco">Francesca Bosco</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Benzothiazoles (adverse effects)</term>
<term>Clozapine (therapeutic use)</term>
<term>Ergolines (adverse effects)</term>
<term>Female</term>
<term>Gambling (chemically induced)</term>
<term>Gambling (drug therapy)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Selegiline (adverse effects)</term>
<term>Serotonin Antagonists (therapeutic use)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Benzothiazoles</term>
<term>Ergolines</term>
<term>Selegiline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Clozapine</term>
<term>Serotonin Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Gambling</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Gambling</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">20669252</PMID>
<DateCreated>
<Year>2010</Year>
<Month>09</Month>
<Day>14</Day>
</DateCreated>
<DateCompleted>
<Year>2010</Year>
<Month>12</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>25</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2010</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Clozapine for medication-related pathological gambling in Parkinson disease.</ArticleTitle>
<Pagination>
<MedlinePgn>1994-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.23177</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Rotondo</LastName>
<ForeName>Alessandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bosco</LastName>
<ForeName>Domenico</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Plastino</LastName>
<ForeName>Massimiliano</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Consoli</LastName>
<ForeName>Arturo</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bosco</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D052160">Benzothiazoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004873">Ergolines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012702">Serotonin Antagonists</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>14611-51-9</RegistryNumber>
<NameOfSubstance UI="D012642">Selegiline</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83619PEU5T</RegistryNumber>
<NameOfSubstance UI="C061333">pramipexole</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>J60AR2IKIC</RegistryNumber>
<NameOfSubstance UI="D003024">Clozapine</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>LL60K9J05T</RegistryNumber>
<NameOfSubstance UI="C047047">cabergoline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D052160">Benzothiazoles</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003024">Clozapine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004873">Ergolines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005715">Gambling</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000139">chemically induced</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012642">Selegiline</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012702">Serotonin Antagonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>12</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1002/mds.23177</ArticleId>
<ArticleId IdType="pubmed">20669252</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001698 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001698 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:20669252
   |texte=   Clozapine for medication-related pathological gambling in Parkinson disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:20669252" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024